drugset / Trial / NCT06969287
Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery
Phase 3
Recruiting
46 enrolled
Washington University School of Medicine
National Institute on Aging (NIA) · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The investigation will establish biological plausibility and infrastructure required for a multisite clinical trial evaluating the re-purposing of fluvoxamine to mitigate postoperative delirium risk in geriatric patients undergoing non-cardiac non-intracranial surgery.
Timeline
- Start
- 2026-04-06
- Primary completion
- 2027-04-01
- Completion
- 2028-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluvoxamine | Unknown | 100 mg | Oral |